Shandong Buchang Pharmaceuticals Co., Ltd. (SHA:603858)
China flag China · Delayed Price · Currency is CNY
15.43
-0.24 (-1.53%)
May 20, 2026, 11:29 AM CST

SHA:603858 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,6891,224818.81694.132,1491,218
Trading Asset Securities
180.0933.08403.75354.09726.45498.17
Cash & Short-Term Investments
1,8691,2581,2231,0482,8751,716
Cash Growth
-12.68%2.86%16.63%-63.54%67.56%-7.73%
Accounts Receivable
1,4761,6121,2581,8871,9052,171
Other Receivables
110.5793.42114.03152.16164.69200.57
Receivables
1,5861,7061,3722,0392,0702,372
Inventory
4,5814,5004,6244,9303,7893,834
Other Current Assets
464.65430.17317.76263.32257.42430.37
Total Current Assets
8,5017,8947,5378,2818,9918,352
Property, Plant & Equipment
4,7124,7965,6646,0006,3015,919
Long-Term Investments
1,3661,4731,5251,4961,4491,433
Goodwill
400.74400.74620.041,4732,0635,133
Other Intangible Assets
804.1849.44809.53949.171,0741,171
Long-Term Accounts Receivable
----16.7523.32
Long-Term Deferred Tax Assets
350.11347.07389.32368.19221.38220.68
Long-Term Deferred Charges
1,9751,9591,6991,3861,125978.44
Other Long-Term Assets
1,5311,5261,085938.55710.55754.32
Total Assets
19,64019,24519,32920,89221,95223,986
Accounts Payable
2,1602,5372,8462,4972,3982,495
Accrued Expenses
115.94387.931,6012,2862,3181,903
Short-Term Debt
417.49358.69486.46240.12638.761,295
Current Portion of Long-Term Debt
--1,123737.93307.04307.42
Current Portion of Leases
--46.0464.3253.6914.96
Current Income Taxes Payable
157.95-81.6483.2995.54118.67
Current Unearned Revenue
300.23352.14215.76238376.52242.4
Other Current Liabilities
3,8443,535702.75709.64773.22786.25
Total Current Liabilities
6,9957,1717,1026,8566,9617,162
Long-Term Debt
2,5332,1321,9862,0982,1271,902
Long-Term Leases
180.7413.7674.62154.58170.3719.14
Long-Term Unearned Revenue
246.08251.37283.59312.29330.55345.63
Long-Term Deferred Tax Liabilities
64.8362.6371.2490.5287.51106.22
Other Long-Term Liabilities
-1783.025.07--
Total Liabilities
10,0209,8089,5209,5169,6779,536
Common Stock
1,0551,0551,1061,1061,1061,142
Additional Paid-In Capital
1,7321,7322,4932,4932,4943,392
Retained Earnings
7,5887,2677,3188,0088,75110,806
Treasury Stock
-118.54--712.38-1.85--934
Comprehensive Income & Other
-35.18-41.9311.2311.8412.1319.3
Total Common Equity
10,22110,01210,21611,61712,36314,425
Minority Interest
-599.87-575.45-408.38-240.98-87.5825.17
Shareholders' Equity
9,6219,4369,80811,37612,27514,450
Total Liabilities & Equity
19,64019,24519,32920,89221,95223,986
Total Debt
3,1312,5043,7163,2953,2973,539
Net Cash (Debt)
-1,263-1,246-2,493-2,247-421.83-1,823
Net Cash Per Share
-1.20-1.18-2.30-2.03-0.38-1.65
Filing Date Shares Outstanding
1,0521,0511,0611,0951,1061,106
Total Common Shares Outstanding
1,0521,0511,0611,1061,1061,106
Working Capital
1,506722.534351,4252,0301,190
Book Value Per Share
9.719.539.6310.5011.1813.04
Tangible Book Value
9,0168,7628,7879,1959,2258,121
Tangible Book Value Per Share
8.578.348.288.318.347.34
Buildings
--4,8915,0365,1953,211
Machinery
--2,3302,0341,8251,578
Construction In Progress
--1,1321,2431,2352,821
Source: S&P Global Market Intelligence. Standard template. Financial Sources.